Use of copeptin in the detection of myocardial ischemia

Clinica Chimica Acta

Volumn 399, Issue 1-2, 2009, Pages 69-73

  Staub, Daniel ^a,b   Morgenthaler, Nils G ^c   Buser, Claudia ^a   Breidthardt, Tobias ^a   Potocki, Mihael ^a   Noveanu, Markus ^a   Reichlin, Tobias ^a   Bergmann, Andreas ^c   Mueller, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c BRAHMS AG   (Germany)

Author keywords

Copeptin; Exercise; Myocardial ischemia; Vasopressin

Indexed keywords

ARGIPRESSIN; COPEPTIN; HORMONE PRECURSOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ERGOMETRY; EXERCISE; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; ARGININE VASOPRESSIN; EXERCISE; GLYCOPEPTIDES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; ROC CURVE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASOCONSTRICTOR AGENTS;

EID: 57049103959     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2008.09.016     Document Type: Article

References (35)

1. Richards A.M., Nicholls M.G., Yandle T.G., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 97 (1998) 1921-1929
2. Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes. Simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105 (2002) 1760-1763
3. Mueller C., Neumann F.J., Perruchoud A.P., et al. Prognostic value of quantitative troponin T measurements in unstable angina/non-ST-segment elevation acute myocardial infarction treated early and predominantly with percutaneous coronary intervention. Am J Med 117 (2004) 897-902
4. Antman E.M., Tanasijevic M.J., Thompson B., et al. Cardiac specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 335 (1996) 1342-1349
5. Möckel M., Danne O., Müller R., et al. Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes. Clin Chim Acta. 393 (2008) 103-109
6. Khan S.Q., Dhillon O.S., O'Brien R.J., et al. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction. Leicester Acute Myocardial Infarction Peptide (LAMP) Study. Circulation 115 (2007) 2103-2110
7. Morgenthaler N.G., Struck J., Alonso C., and Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 52 (2006) 112-119
8. Itoi K., Jiang Y.Q., Iwasaki Y., et al. Regulatory mechanisms of corticotropin-releasing hormone and vasopressin gene expression in the hypothalamus. J Neuroendocrinol 16 (2004) 348-355
9. Katan M., Morgenthaler N., Widmer I., et al. Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level. Neuro Endocrinol Lett. 29 (2008) 341-346
10. Zellweger M.J., Lewin H.C., Lai S., et al. When to stress patients after coronary artery bypass grafting? Risk stratification in patients early and late post-CABG using stress myocardial perfusion SPECT: implications of appropriate clinical strategies. J Am Coll Cardiol 37 (2001) 144-152
11. Zellweger M.J., Weinbacher M., Zutter A.W., et al. Long-term outcome of patients with silent versus symptomatic ischemia six months after percutaneous coronary intervention and stenting. J Am Coll Cardiol 42 (2003) 33-40
12. Fox K., Garcia M.A., Ardissino D., et al. Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 27 (2006) 1341-1381
13. Berman D.S., Kiat H., Friedman J.D., et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 22 (1993) 1455-1464
14. Hachamovitch R., Berman D.S., Shaw L.J., et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 97 (1998) 535-543
15. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
16. Singh Ranger G. The physiology and emerging roles of antidiuretic hormone. Int J Clin Pract 56 (2002) 777-782
17. de Bree F.M., and Burbach J.P. Structure-function relationships of the vasopressin prohormone domains. Cell Mol Neurobiol 18 (1998) 173-191
18. Dunser M.W., Mayr A.J., Ulmer H., et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 107 (2003) 2313-2319
19. Wade C.E., and Claybaugh J.R. Plasma renin activity, vasopressin concentration, and urinary excretory responses to exercise in men. J Appl Physiol 49 (1980) 930-936
20. Radke K.J., King K.B., Blair M.L., Fitzpatrick P.G., and Eldredge D.H. Hormonal responses to the 6-minute walk test in women and men with coronary heart disease: a pilot study. Heart Lung 34 (2005) 126-135
21. Takamata A., Nose H., Kinoshita T., et al. Effect of acute hypoxia on vasopressin release and intravascular fluid during dynamic exercise in humans. Am J Physiol Regul Integr Comp Physiol 279 (2000) R161-168
22. Wade C.E. Response, regulation, and actions of vasopressin during exercise: a review. Med Sci Sports Exerc 16 (1984) 506-511
23. Stebbins C.L., Symons J.D., McKirnan M.D., and Hwang F.F. Factors associated with vasopressin release in exercising swine. Am J Physiol 266 (1994) R118-124
24. Tolg R., Witt M., Schwarz B., et al. Comparison of carvedilol and metoprolol in patients with acute myocardial infarction undergoing primary coronary intervention-the PASSAT Study. Clin Res Cardiol 95 (2006) 31-41
25. Stoiser B., Mortl D., Hulsmann M., et al. Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure. Eur J Clin Invest 36 (2006) 771-778
26. Kirlin P.C., Grekin R., Das S., et al. Neurohumoral activation during exercise in congestive heart failure. Am J Med 81 (1986) 623-629
27. Foote R.S., Pearlman J.D., Siegel A.H., et al. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol 44 (2004) 1980-1987
28. Staub D., Jonas N., Zellweger M.J., et al. Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia. Am J Med 118 (2005) 1287.e9-1287.e16
29. Staub D., Nusbaumer C., Zellweger M.J., et al. Use of B-type natriuretic peptide in the detection of myocardial ischemia. Am Heart J 151 (2006) 1223-1230
30. Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 44 (2004) 1988-1995
31. Morgenthaler N.G., Müller B., Struck J., Bergmann A., Redl H., and Christ-Crain M. Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock. 28 (2007) 219-226
32. Gegenhuber A., Struck J., Dieplinger B., et al. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure. J Card Fail. 13 (2007) 42-49
33. Müller B., Morgenthaler N., Stolz D., et al. Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections. Eur J Clin Invest. 37 (2007) 145-152
34. White C.W., Wright C.B., Doty D.B., et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis?. N Engl J Med 310 (1984) 819-824
35. Pijls N.H., De Bruyne B., Peels K., et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 334 (1996) 1703-1708